Literature DB >> 3826498

Non-01 Vibrio cholerae infections in Cancun, Mexico.

M J Finch, J L Valdespino, J G Wells, G Perez-Perez, F Arjona, A Sepulveda, D Bessudo, P A Blake.   

Abstract

To determine the role of Vibrio cholerae as a cause of diarrheal illness in Cancun, Mexico, an investigation was conducted in July and August 1983. Although toxigenic V. cholerae 01 were not found, non-01 V. cholerae were isolated from 22 (16%) of 134 stools from persons with diarrheal illness and none of 22 stools from well persons; 58 (92%) of 63 sewage samples; 12 (86%) of 14 untreated well water samples; a home storage tank for treated water; and 5 (21%) of 24 samples of raw seafood. None of the V. cholerae isolates from patients were toxigenic. The illness occurred mainly in small children, and were characterized principally by diarrhea and abdominal pain. No patient was seriously ill, and all recovered without sequelae. Seven different serotypes of non-01 V. cholerae were isolated from the stool specimens, and Smith serotype 12 accounted for 10 (46%) of the 22 isolates. A matched-pair case-control study found that cases were more likely than controls to have eaten home prepared gelatin (P = 0.03, OR = 5/0) and seafood (P = 0.06, OR = 4/0).

Entities:  

Mesh:

Year:  1987        PMID: 3826498     DOI: 10.4269/ajtmh.1987.36.393

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells.

Authors:  P Panigrahi; B D Tall; R G Russell; L J Detolla; J G Morris
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  Use of a synthetic oligonucleotide probe to detect strains of non-serovar O1 Vibrio cholerae carrying the gene for heat-stable enterotoxin (NAG-ST).

Authors:  C W Hoge; O Sethabutr; L Bodhidatta; P Echeverria; D C Robertson; J G Morris
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Unusual non-serogroup O1 Vibrio cholerae bacteremia associated with liver disease.

Authors:  R Dhar; M A Ghafoor; A Y Nasralah
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.

Authors:  C Sharma; M Thungapathra; A Ghosh; A K Mukhopadhyay; A Basu; R Mitra; I Basu; S K Bhattacharya; T Shimada; T Ramamurthy; T Takeda; S Yamasaki; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae.

Authors:  J A Johnson; J G Morris; J B Kaper
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Non-O1 Vibrio cholerae intestinal pathology and invasion in the removable intestinal tie adult rabbit diarrhea model.

Authors:  R G Russell; B D Tall; J G Morris
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice.

Authors:  J A Johnson; P Panigrahi; J G Morris
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Fish as reservoirs and vectors of Vibrio cholerae.

Authors:  Yigal Senderovich; Ido Izhaki; Malka Halpern
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa.

Authors:  Lucantonio Debellis; Anna Diana; Diletta Arcidiacono; Romina Fiorotto; Piero Portincasa; Donato Francesco Altomare; Carlo Spirlì; Marina de Bernard
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.